Articles with public access mandates - John LukLearn more
Not available anywhere: 3
Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients
S Sun, MZ Xu, RT Poon, PJ Day, JM Luk
Journal of proteome research 9 (1), 70-78, 2010
Mandates: US National Institutes of Health
Clinical correlation of cadherin‐17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma
BH Zheng, S Shen, KF Wong, ZJ Gong, WT Sun, XJ Ni, JW Wang, MY Hu, ...
Journal of Surgical Oncology 123 (5), 1253-1262, 2021
Mandates: US National Institutes of Health, National Natural Science Foundation of China
The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer
XM Pei, HT Wong, SSM Ng, WW Leung, YN Wong, HF Tsang, AKC Chan, ...
Expert Review of Molecular Diagnostics 23 (2), 171-179, 2023
Mandates: Research Grants Council, Hong Kong
Available somewhere: 19
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
L Zender, MS Spector, W Xue, P Flemming, C Cordon-Cardo, J Silke, ...
Cell 125 (7), 1253-1267, 2006
Mandates: German Research Foundation
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23. 3
IPM Tomlinson, E Webb, L Carvajal-Carmona, P Broderick, K Howarth, ...
Nature genetics 40 (5), 623-630, 2008
Mandates: Cancer Research UK, Chief Scientist Office, Scottish Executive
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
MZ Xu, TJ Yao, NPY Lee, IOL Ng, YT Chan, L Zender, SW Lowe, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer
L Zender, W Xue, J Zuber, CP Semighini, A Krasnitz, B Ma, P Zender, ...
Cell 135 (5), 852-864, 2008
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, German …
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma
KJ Yong, C Gao, JSJ Lim, B Yan, H Yang, T Dimitrov, A Kawasaki, ...
New England Journal of Medicine 368 (24), 2266-2276, 2013
Mandates: US National Institutes of Health
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
MZ Xu, SW Chan, AM Liu, KF Wong, ST Fan, J Chen, RT Poon, L Zender, ...
Oncogene 30 (10), 1229-1240, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
G Sethi, S Chatterjee, P Rajendran, F Li, MK Shanmugam, KF Wong, ...
Molecular cancer 13, 1-14, 2014
Mandates: Department of Biotechnology, India, Department of Science & Technology …
Targeting cadherin‐17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma
LX Liu, NP Lee, VW Chan, W Xue, L Zender, C Zhang, M Mao, H Dai, ...
Hepatology 50 (5), 1453-1463, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS
M McMahon, A Contreras, M Holm, T Uechi, CM Forester, X Pang, ...
Elife 8, e48847, 2019
Mandates: US National Institutes of Health
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation
JH Kim, BH Sohn, HS Lee, SB Kim, JE Yoo, YY Park, W Jeong, SS Lee, ...
PLoS medicine 11 (12), e1001770, 2014
Mandates: US National Institutes of Health
Refinement of the basis and impact of common 11q23. 1 variation to the risk of developing colorectal cancer
AM Pittman, E Webb, L Carvajal-Carmona, K Howarth, MC Di Bernardo, ...
Human molecular genetics 17 (23), 3720-3727, 2008
Mandates: Cancer Research UK
Activation of interleukin‐6–induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation …
SP Lam, JM Luk, K Man, KTP Ng, CK Cheung, S Rose‐John, CM Lo
Liver Transplantation 16 (10), 1195-1206, 2010
Mandates: German Research Foundation
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma
NP Lee, L Chen, MC Lin, FH Tsang, C Yeung, RT Poon, J Peng, X Leng, ...
Journal of proteome research 8 (3), 1293-1303, 2009
Mandates: US National Institutes of Health
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122
DR Boutz, PJ Collins, U Suresh, M Lu, CM Ramírez, ...
Journal of Biological Chemistry 286 (20), 18066-18078, 2011
Mandates: US National Institutes of Health
Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma
KF Wong, AM Liu, W Hong, Z Xu, JM Luk
Oncotarget 7 (47), 77683, 2016
Mandates: National Natural Science Foundation of China
Prognostic model to predict postoperative acute kidney injury in patients undergoing major gastrointestinal surgery based on a national prospective observational cohort study
STARSurg Collaborative, ...
BJS open 2 (6), 400-410, 2018
Mandates: British Heart Foundation, Cancer Research UK, National Institute for Health …
Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma
Y Wang, FH Shek, KF Wong, LX Liu, XQ Zhang, Y Yuan, E Khin, M Hu, ...
PloS one 8 (9), e72386, 2013
Mandates: Research Grants Council, Hong Kong
Publication and funding information is determined automatically by a computer program